Summary:
Click image to enlarge
Arizona Liver Health is conducting a study to see if an investigational medicine (study drug) can safely treat and participants with chronic hepatitis B virus.
Qualified Participants Must:
• Patients who are 18-65 years
•
Must have Hepatitis B (HBV) infection
•
Have not received treatment
Qualified Participants May Receive:
Qualified participants may receive the study drug at zero extra cost and may receive compensation for trial related time & travel.